BR112015022415A2 - composições de cisplatina lipossômica para terapia contra câncer - Google Patents
composições de cisplatina lipossômica para terapia contra câncerInfo
- Publication number
- BR112015022415A2 BR112015022415A2 BR112015022415A BR112015022415A BR112015022415A2 BR 112015022415 A2 BR112015022415 A2 BR 112015022415A2 BR 112015022415 A BR112015022415 A BR 112015022415A BR 112015022415 A BR112015022415 A BR 112015022415A BR 112015022415 A2 BR112015022415 A2 BR 112015022415A2
- Authority
- BR
- Brazil
- Prior art keywords
- cisplatin
- cancer therapy
- mol
- liposomal
- liposomal cisplatin
- Prior art date
Links
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 title abstract 6
- 229960004316 cisplatin Drugs 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000011275 oncology therapy Methods 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 239000002502 liposome Substances 0.000 abstract 2
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- -1 phosphatidylcholine lipid Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780272P | 2013-03-13 | 2013-03-13 | |
| PCT/US2014/026341 WO2014160337A1 (en) | 2013-03-13 | 2014-03-13 | Liposomal cisplatin compositions for cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015022415A2 true BR112015022415A2 (pt) | 2017-07-18 |
Family
ID=50439522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015022415A BR112015022415A2 (pt) | 2013-03-13 | 2014-03-13 | composições de cisplatina lipossômica para terapia contra câncer |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10039716B2 (enExample) |
| EP (1) | EP2968142A1 (enExample) |
| JP (1) | JP6077710B2 (enExample) |
| CN (1) | CN105209017A (enExample) |
| BR (1) | BR112015022415A2 (enExample) |
| CA (1) | CA2903254C (enExample) |
| MX (1) | MX2015012199A (enExample) |
| WO (1) | WO2014160337A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5994049B2 (ja) * | 2012-10-01 | 2016-09-21 | 兵神装備株式会社 | 吐出システム |
| US9895313B2 (en) | 2015-03-03 | 2018-02-20 | Cureport, Inc. | Combination liposomal pharmaceutical formulations |
| CN107530291A (zh) * | 2015-03-03 | 2018-01-02 | 奎尔波特股份有限公司 | 双重负载的脂质体药物制剂 |
| US20170049701A1 (en) * | 2015-08-05 | 2017-02-23 | Steven M. Kushner | Clustoidal multilamellar soy lecithin phospholipid structures for transdermal, transmucosal, or oral delivery, improved intestinal absorption, and improved bioavailability of nutrients |
| US20180344644A1 (en) * | 2015-09-21 | 2018-12-06 | Mallinckrodt Llc | Improved stability of liposome formulations and uses thereof |
| CR20180388A (es) * | 2016-01-07 | 2018-09-11 | Univ Western Health Sciences | Formulaciones para el tratamiento del cáncer de vejiga |
| WO2017142876A1 (en) | 2016-02-15 | 2017-08-24 | University Of Georgia Research Foundation, Inc. | lPA-3-LOADED LIPOSOMES AND METHODS OF USE THEREOF |
| EP3458028A1 (en) * | 2016-05-16 | 2019-03-27 | Infectious Disease Research Institute | Pegylated liposomes and methods of use |
| MA47319A (fr) * | 2017-01-18 | 2019-11-27 | Temasek Life Sciences Laboratory Ltd | Liposomes hyperstabilisés augmentant le ciblage de cellules mitotiques |
| EP3706801A4 (en) * | 2017-11-08 | 2022-04-06 | L.E.A.F Holdings Group LLC | PLATINUM COMPLEXES AND USES THEREOF |
| WO2021183588A1 (en) | 2020-03-10 | 2021-09-16 | Chung Yuan Christian University | Liposome composition and preparation method thereof |
| TW202345843A (zh) * | 2022-04-06 | 2023-12-01 | 財團法人國家衛生研究院 | 脂質奈米顆粒及脂質體 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843473A (en) * | 1989-10-20 | 1998-12-01 | Sequus Pharmaceuticals, Inc. | Method of treatment of infected tissues |
| US20020009488A1 (en) * | 1995-05-03 | 2002-01-24 | Polymasc Pharmaceuticals Plc | Tissue entrapment |
| ES2208946T3 (es) * | 1996-08-23 | 2004-06-16 | Sequus Pharmaceuticals, Inc. | Liposomas que contienen un compuesto de cisplatino. |
| UA71540C2 (uk) | 1997-02-05 | 2004-12-15 | Фармація Енд Апджон Компані | Спосіб одержання ліпідних комплексів або ліпосом водонерозчинного діаміноциклогексанкарбоксилату платини та фармацевтична композиція, що містить ліпідний комплекс або ліпосоми водонерозчинного діаміноциклогексанкарбоксилату платини |
| ES2236181T3 (es) * | 2000-01-28 | 2005-07-16 | Alza Corporation | Liposomas que contienen un compuesto atrapado en una solucion supersaturada. |
| WO2002036073A2 (en) * | 2000-11-02 | 2002-05-10 | Smithkline Beecham Corporation | Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| US20050118249A1 (en) | 2001-11-13 | 2005-06-02 | Murray Webb | Lipid carrier compositions and methods for improved drug retention |
| EP1674081A1 (de) * | 2004-12-23 | 2006-06-28 | KTB Tumorforschungsgesellschaft mbH | Herstellung von lipidbasierten Nanopartikeln unter Einsatz einer dualen asymmetrischen Zentrifuge |
| JP2006248978A (ja) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
| EP1716870A1 (en) * | 2005-04-29 | 2006-11-02 | Bracco Imaging S.p.A. | MRI contrast agents endowed with concentration independent responsiveness |
| US20100034874A1 (en) | 2006-12-08 | 2010-02-11 | Katayama Chemical Industries Co., Ltd. | Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome |
-
2014
- 2014-03-13 MX MX2015012199A patent/MX2015012199A/es unknown
- 2014-03-13 CA CA2903254A patent/CA2903254C/en not_active Expired - Fee Related
- 2014-03-13 BR BR112015022415A patent/BR112015022415A2/pt not_active IP Right Cessation
- 2014-03-13 WO PCT/US2014/026341 patent/WO2014160337A1/en not_active Ceased
- 2014-03-13 CN CN201480026589.0A patent/CN105209017A/zh active Pending
- 2014-03-13 JP JP2016502107A patent/JP6077710B2/ja not_active Expired - Fee Related
- 2014-03-13 US US14/208,297 patent/US10039716B2/en not_active Expired - Fee Related
- 2014-03-13 EP EP14715517.0A patent/EP2968142A1/en not_active Withdrawn
-
2018
- 2018-07-09 US US16/030,575 patent/US10383823B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20180318219A1 (en) | 2018-11-08 |
| JP6077710B2 (ja) | 2017-02-08 |
| US20140271821A1 (en) | 2014-09-18 |
| CA2903254C (en) | 2019-04-09 |
| MX2015012199A (es) | 2015-11-30 |
| EP2968142A1 (en) | 2016-01-20 |
| US10039716B2 (en) | 2018-08-07 |
| JP2016513651A (ja) | 2016-05-16 |
| CN105209017A (zh) | 2015-12-30 |
| CA2903254A1 (en) | 2014-10-02 |
| WO2014160337A1 (en) | 2014-10-02 |
| US10383823B2 (en) | 2019-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015022476A2 (pt) | composições de oxaliplatina de lipossoma para terapia de câncer | |
| BR112015022415A2 (pt) | composições de cisplatina lipossômica para terapia contra câncer | |
| BR112015022819A8 (pt) | método para a preparação de um taxano lipossomal, composição compreendendo um lipossoma e taxano lipossomal | |
| BR112014015333A2 (pt) | composições lipossomais de clorito ou clorato | |
| UA109991C2 (xx) | Карбаматні сполуки, їх отримання і застосування | |
| AR091006A1 (es) | Formulaciones de testosterona proliposomal | |
| BR112014010291A2 (pt) | composições de lipossoma combinacionais para terapia de câncer | |
| BR112015008480A2 (pt) | compostos de benzeno substituído | |
| BR112015008447A2 (pt) | métodos para tratar câncer | |
| BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
| EP4360712A3 (en) | Aryl- or heteroaryl-substituted benzene compounds | |
| EA201500535A1 (ru) | Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и насыщения, снижения веса, композиция, фармацевтическая композиция, косметическая композиция и лекарственное средство | |
| GEP201706734B (en) | FORMULATION FOR ANTI-α4β7 ANTIBODY | |
| BR112013010556A2 (pt) | métodos e composições adequadas para a promoção de uma pele saudável | |
| MX2014008189A (es) | Composiciones y metodos para tratar trastornos metabolicos. | |
| BR112015023153A2 (pt) | utilização de um composto e composto | |
| IN2015DN03219A (enExample) | ||
| BR112015000174A2 (pt) | método para o tratamento da artrite | |
| BR112015001313A2 (pt) | composições de vacina | |
| BR112012012862A2 (pt) | composição farmacêutica compreendendo oligopeptídeos | |
| BR112012027092A2 (pt) | métodos e composiões para reduzir ou impedir a calcificação vascular durante a terapia de diálise peritoneal | |
| BR112013024824A2 (pt) | ésteres isopentílicos para uso em composições cosméticas, dermatológicas ou farmacêuticas | |
| MX388073B (es) | Composición farmacéutica, preparación y usos de la misma. | |
| BR112013026698A2 (pt) | formulações do tipo tópica compreendendo depsipeptídeo cíclico | |
| MX2016000294A (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2623 DE 13/04/2021. |